Lexeo Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Lexeo Therapeutics is registering for the resale of up to 6,974,248 shares of its common stock by selling stockholders after a recent private placement.